According to FutureWise analysis the market for Meningitis Vaccine in 2023 is US$ 4.34 billion, and is expected to reach US$ 7.25 billion by 2031 at a CAGR of 6.62%.
Meningitis is an uncommon illness that affects the meninges, which are the fragile membranes that protect the brain and spinal cord. When patients sick with meningitis cough or sneeze, the germs that cause meningitis can spread. Meningococcal meningitis is an infection caused by the bacterium Neisseria meningitidis. Bacterial meningitis may strike anyone at any age. Infants, on the other hand, are more likely to acquire bacterial meningitis. Increasing government and regulatory initiatives to combat the rising prevalence of meningitis are expected to drive growth in the global meningitis vaccines market over the forecast period. The COVID-19 pandemic had a severe economic impact on the worldwide meningitis vaccinations industry, leading to a drop in meningitis vaccination rates. According to an article published by Elsevier B.V., a Netherlands-based academic publishing company specialising in scientific, technical, and medical content, the number of meningococcal C (Men-C) conjugate vaccine doses administered. Bacteria, viruses, fungi, and non-infectious disorders can all cause meningitis. Meningitis symptoms include a headache, fever, and a stiff neck that makes dropping the chin to the chest difficult or impossible, however babies may not have a stiff neck and symptoms may differ in the elderly and those who use immune suppressing medications. Vaccination is a risk-free way to establish immunity to meningitis. Immunization of those most at risk of infection protects them against meningitis, limits its spread within communities, and eventually benefits the whole community.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Meningitis Vaccine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Meningitis Vaccine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.